Drug design based on biosynthetic studies: Synthesis, biological activity, and kinetics of new inhibitors of 2,3-oxidosqualene cyclase and squalene epoxidase
- 31 May 1989
- Vol. 53 (3-5) , 363-391
- https://doi.org/10.1016/0039-128x(89)90020-2
Abstract
No abstract availableKeywords
This publication has 55 references indexed in Scilit:
- The squalene‐2,3‐epoxide cyclase as a model for the development of new drugsLipids, 1986
- Cholesterol and the cell membraneBiochimica et Biophysica Acta (BBA) - Reviews on Biomembranes, 1985
- The transformation of 10α-cucurbita-5,24-dien-3β-ol into cucurbitacin C by seedlings of Cucumis sativusPhytochemistry, 1983
- New Chemicals Promise Larger CropsScience, 1981
- Biosynthesis of Cucurbitacins inBryonia dioicaSeedlingsPlanta Medica, 1981
- Effect of the configuration of the methyl group at C‐4 on the capacity of 4‐methyl‐9β, 19‐cyclosteroids to be substrates of a cyclopropane cleavage enzyme from maizeJournal of Oil & Fat Industries, 1979
- Sex hormones of the aquatic fungusAchlyaLipids, 1978
- Insect steroid metabolismLipids, 1978
- The function of sterols in membranesBiochimica et Biophysica Acta (BBA) - Reviews on Biomembranes, 1976
- Cyclisation of 1-trans-1′-norsqualene-2,3-epoxide and 1-cis-1′-norsqualene-2,3-epoxide by a cell free system of corn embryosPhytochemistry, 1976